Product
fosmanogepix
1 clinical trial
1 indication
Indication
Invasive Fungal InfectionsClinical trial
A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of APX001 in the Treatment of Patients With Invasive Mold Infections Caused by Aspergillus Species or Rare MoldsStatus: Terminated, Estimated PCD: 2022-03-29